Ertel W, Scholl F A, Gallati H, Bonaccio M, Schildberg F W, Trentz O
Department of Surgery, University of Zurich, Switzerland.
Arch Surg. 1994 Dec;129(12):1330-6; discussion 1336-7. doi: 10.1001/archsurg.1994.01420360120017.
To examine the kinetics of altered soluble tumor necrosis factor receptors (sTNFRs) released in patients with severe sepsis, their correlation with the morbidity and mortality of these patients, and the role of endotoxin to induce cleavage of sTNFRs.
Soluble TNFR levels in plasma obtained from 40 patients with severe sepsis (mean [+/- SD] Acute Physiology and Chronic Health Evaluation [APACHE] II score, 27.9 +/- 7.0 points) on days 0, 1, 3, 5, and 10 after sepsis diagnosis were measured using specific enzyme-linked immunological binding assays and compared with levels in 75 control patients without infection. In addition, an ex vivo model consisting of lipopolysaccharide stimulation of human whole blood as a relevant physiological milieu was used. Blood from patients with sepsis and control patients was incubated in the presence or absence of lipopolysaccharide (1 mg/L) for 0, 1, 2, 4, 8, and 24 hours. Plasma levels of sTNFRs from both groups were determined using the enzyme-linked immunological binding assays.
In patients with sepsis, plasma levels of both sTNFRs were markedly (P < .01) increased during the whole observation period, compared with those of control patients, and correlated (P < .001) with the simultaneously obtained APACHE II and multiple organ failure scores, as well as with mortality. Although incubation of whole blood with lipopolysaccharide increased the release of sTNFR p55 and p75 in both groups, sTNFR concentrations in blood from control patients remained low compared with those of patients with severe sepsis, despite stimulation of whole blood with a maximum lipopolysaccharide concentration.
These data indicate that an enhanced release of sTNFRs during severe sepsis is not solely induced by endotoxin. Since the degree of increased sTNFR levels portended poorly for patient survival, elevated sTNFR levels may represent a good marker for severity of sepsis, thus predicting outcome.
研究重症脓毒症患者体内可溶性肿瘤坏死因子受体(sTNFRs)释放的动力学变化,其与患者发病率和死亡率的相关性,以及内毒素在诱导sTNFRs裂解中的作用。
采用特异性酶联免疫结合测定法,检测40例重症脓毒症患者(急性生理与慢性健康状况评分系统[APACHE]Ⅱ评分均值[±标准差]为27.9±7.0分)在脓毒症诊断后第0、1、3、5和10天血浆中可溶性TNFR水平,并与75例未感染的对照患者的水平进行比较。此外,使用由脂多糖刺激人全血构成的体外模型作为相关生理环境。将脓毒症患者和对照患者的血液在有或无脂多糖(1mg/L)存在的情况下孵育0、1、2、4、8和24小时。采用酶联免疫结合测定法测定两组患者血浆中sTNFRs水平。
与对照患者相比,脓毒症患者在整个观察期内血浆中两种sTNFRs水平均显著升高(P<0.01),并与同时获得的APACHEⅡ评分、多器官功能衰竭评分以及死亡率相关(P<0.001)。尽管脂多糖孵育人全血增加了两组中sTNFR p55和p75的释放,但尽管用最大脂多糖浓度刺激全血,对照患者血液中的sTNFR浓度仍低于重症脓毒症患者。
这些数据表明,重症脓毒症期间sTNFRs释放增加并非仅由内毒素诱导。由于sTNFR水平升高程度预示患者生存预后不良,因此升高的sTNFR水平可能是脓毒症严重程度的良好标志物,从而可预测预后。